US$ 27.29
compounded tirzepatide ro GLP-1/GIP (Tirzepatide) Eli Lilly strikes Zepbound deal
Description
GLP-1 receptor agonists (such as semaglutide) and dual agonists like tirzepatide have transformed obesity and diabetes management

Start a telehealth weight-loss program with EBO MD

Stat News called for dropping GLP-1 as a single target

Discover the mechanisms behind this common side effect, how often it occurs, proven management strategies, and warning signs that require medical attention for safe treatment.

I hope my friends in the compounding community call out this type of behavior and if I were one of the manufacturers of current approved GLP-1s (Novo Nordisk, Eli Lilly and Company, etc), I would explore legal action against any company who is blatantly abusing #drugshortage loopholes to engage in manufacturing and not #compounding
